These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 32853954)

  • 1. The value of microRNAs as the novel biomarkers for colorectal cancer diagnosis: A meta-analysis.
    Zuo Z; Jiang Y; Zeng S; Li Y; Fan J; Guo Y; Tao H
    Pathol Res Pract; 2020 Oct; 216(10):153130. PubMed ID: 32853954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Value of Fecal MicroRNAs for Colorectal Cancer: a Meta-Analysis.
    Wang C; Zhao K; Rong Q
    Clin Lab; 2015; 61(12):1845-53. PubMed ID: 26882806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of microRNA-21 expression as a potential screening biomarker for colorectal cancer: a meta-analysis.
    Jiang JX; Zhang N; Liu ZM; Wang YY
    Asian Pac J Cancer Prev; 2014; 15(18):7583-8. PubMed ID: 25292032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Accuracy of Single MicroRNAs in Peripheral Blood to Diagnose Ovarian Cancer: An Updated Meta-Analysis.
    Cui Y; Hong S; Zhu X
    Dis Markers; 2020; 2020():1075942. PubMed ID: 32025275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive power of circulating miRNAs in detecting colorectal cancer.
    Zeng W; Tu Y; Zhu Y; Wang Z; Li C; Lao L; Wu G
    Tumour Biol; 2015 Apr; 36(4):2559-67. PubMed ID: 25527153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs as Biomarkers for the Diagnostics of Bladder Cancer: a Meta-Analysis.
    Chen L; Cui Z; Liu Y; Bai Y; Lan F
    Clin Lab; 2015; 61(8):1101-8. PubMed ID: 26427157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA panels as diagnostic biomarkers for colorectal cancer: A systematic review and meta-analysis.
    Sur D; Advani S; Braithwaite D
    Front Med (Lausanne); 2022; 9():915226. PubMed ID: 36419785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A panel of circulating miRNAs as diagnostic biomarkers for screening multiple myeloma: a systematic review and meta-analysis.
    Zhang L; Cao D; Tang L; Sun C; Hu Y
    Int J Lab Hematol; 2016 Dec; 38(6):589-599. PubMed ID: 27870469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited diagnostic value of microRNAs for detecting colorectal cancer: a meta-analysis.
    Zhou XJ; Dong ZG; Yang YM; Du LT; Zhang X; Wang CX
    Asian Pac J Cancer Prev; 2013; 14(8):4699-704. PubMed ID: 24083729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs used as novel biomarkers for detecting cancer metastasis.
    Han C; Yu H; Zhang L; Li X; Feng Y; Xin H
    Tumour Biol; 2015 Mar; 36(3):1755-62. PubMed ID: 25366141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of circulating microRNAs in thyroid carcinoma: A systematic review and meta-analysis.
    Xu SL; Tian YY; Zhou Y; Liu LQ
    Clin Endocrinol (Oxf); 2020 Oct; 93(4):489-498. PubMed ID: 32379941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-17 family as novel biomarkers for cancer diagnosis: a meta-analysis based on 19 articles.
    Gu R; Huang S; Huang W; Li Y; Liu H; Yang L; Huang Z
    Tumour Biol; 2016 May; 37(5):6403-11. PubMed ID: 26631037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic role of circulating MiR-21 in colorectal cancer: a update meta-analysis.
    Liu T; Liu D; Guan S; Dong M
    Ann Med; 2021 Dec; 53(1):87-102. PubMed ID: 33108223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of circulating microRNAs for gastric cancer in Asian populations: a meta-analysis.
    Liu L; Wang S; Cao X; Liu J
    Tumour Biol; 2014 Dec; 35(12):11995-2004. PubMed ID: 25159040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs as Potential Biomarkers for Diagnosing Cancers of Central Nervous System: a Meta-analysis.
    Wei D; Wan Q; Li L; Jin H; Liu Y; Wang Y; Zhang G
    Mol Neurobiol; 2015; 51(3):1452-61. PubMed ID: 25081587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of circulating miR-21 for colorectal cancer: a meta-analysis.
    Shan L; Ji Q; Cheng G; Xia J; Liu D; Wu C; Zhu B; Ding Y
    Cancer Biomark; 2015; 15(1):47-56. PubMed ID: 25524942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs as novel biomarkers for the differentiation of malignant versus benign thyroid lesions: a meta-analysis.
    Zhou GJ; Xiao M; Zhao LN; Tang JG; Zhang L
    Genet Mol Res; 2015 Jul; 14(3):7279-89. PubMed ID: 26214406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of circulating microRNA biomarkers for breast cancer detection: a meta-analysis.
    Liu L; Wang S; Cao X; Liu J
    Tumour Biol; 2014 Dec; 35(12):12245-53. PubMed ID: 25195131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The accuracy of circulating microRNA-21 in the diagnosis of colorectal cancer: a systematic review and meta-analysis.
    Xu F; Xu L; Wang M; An G; Feng G
    Colorectal Dis; 2015 May; 17(5):O100-7. PubMed ID: 25683351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Value of Potential MicroRNAs in CRC: A Meta-Analysis.
    Fathi S; Guessous F; Karkouri M
    Microrna; 2022; 11(3):190-205. PubMed ID: 35616664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.